Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is Michelle and I will facilitate today ...
In situations with more favorable market access contracts, Novavax is demonstrating the ability to compete with the mRNA ...
So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and ...
So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and ...
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
With boric acid, the process affords an aqueous solution of tetrafluoroboric ... This study represents an important step ...
The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...
Jacob Johnson; Analyst; Stephens Inc. Good day, ladies and gentlemen, and welcome to Repligen Corporation's third-quarter of 2024 earnings conference call. My name is Chad, and I will be your ...